DIAGNOSIS AND TREATMENT OF CHRONIC FATIGUE SYNDROME FROM VARIATIONS IN ARGININE-VASOPRESSIN RECEPTOR 2

摘要

The invention provides methods of diagnosing and treating chronic fatigue syndrome. These methods are premised, in part, on a newly discovered correlation between variations in the arginine-vasopressin receptor gene-2 (AVPR2) correlate and susceptibility to chronic fatigue syndrome. Susceptibility to the syndrome is diagnosed by detecting variations in AVPR2. The syndrome is treated by administration of salt, agents that promote salt retention or agents that antagonize binding of AVP to AVPR2.